USA gives green signal to Pfizer-BioNtech, India ensures no compromise in development of the vaccine.

Pfzier has been accepted by the USA and india is ensuring of no compromise when it comes to vaccine development

The USA government advisory panel commended the immediate approval of the Pfizer-BioNTech coronavirus vaccine, emphasizing that the benefits of shooting outweigh its risks. The authorization came at a time when the epidemic has pushed medical facilities across the US to the brim.

In India, Union Health Minister Harsh Vardhan said a coronavirus vaccine was expected to be available in the coming weeks and with a firm view, it ensured there was no compromise in scientific and regulatory practices. He also added that the government had reviewed the current demand for vaccines and was working to increase capacity, health infrastructure and staff."The vaccine is expected to be available in the next few weeks and the vaccination process will begin in India as soon as it is approved by the relevant legal agency."

The US government advisory panel has approved the extensive use of Pfizer's coronavirus vaccine. Shooting can begin within days, according to the Food and Drug Administration (FDA).Government advisers on Thursday concluded that the vaccine from Pfizer and its German counterpart BioNTech looks safe and effective in using emergency services for adults and young people 16 and older.

The approval came despite questions about the allergies noticed in two people who received the vaccine earlier this week when Britain became the first country to launch the Pfizer-BioNTech doses.An independent review of non-governmental experts on the development of vaccines, infectious diseases and medical statistics was considered important to boost Americans' confidence in the doses safety, which was built at breakneck speed less than a year after the virus was discovered.

Pfizer said he would have about 25 million doses of vaccine shot by the US in late December. But the first goods will be limited and reserved for health care workers and elderly residents, and other vulnerable groups next time until the discovery becomes more widely available on demand, something that will not happen until spring.

Experts estimate that at least 70 percent of the US population will need to be vaccinated to achieve herd protection.The first set of Pfizer vaccine doses will also have to reach Canada, allowing authorities to launch a campaign to end the second wave.